← Back to Search

Heated Humidified High-flow Nasal Cannula for Chronic Obstructive Pulmonary Disease

N/A
Waitlist Available
Led By Joshua Wald, MD
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up collected throughout inpatient enrollment period until last enrolled patient discharged (expected total of 70 days)
Awards & highlights

Study Summary

This trial is testing whether using a device to deliver heated humidified air to patients with COPD will help to clear mucous from their lungs and reduce exacerbations.

Eligible Conditions
  • Chronic Obstructive Pulmonary Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~collected throughout inpatient enrollment period until last enrolled patient discharged (expected total of 70 days)
This trial's timeline: 3 weeks for screening, Varies for treatment, and collected throughout inpatient enrollment period until last enrolled patient discharged (expected total of 70 days) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
ER use or hospitalization for COPD
Secondary outcome measures
Hospital length of stay
Use of home-care resources
Other outcome measures
Average daily use of heated humidified high-flow nasal cannula
Drop out rate
Number of eligible patients who consent to the trial
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Heated humidified high-flowExperimental Treatment1 Intervention
Heated Humidified High-flow Nasal Cannula

Find a Location

Who is running the clinical trial?

McMaster UniversityLead Sponsor
880 Previous Clinical Trials
2,597,798 Total Patients Enrolled
Fisher and Paykel HealthcareIndustry Sponsor
120 Previous Clinical Trials
9,918 Total Patients Enrolled
Joshua Wald, MDPrincipal InvestigatorMcMaster University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
European Respiratory JournalJournal
Chronic Mucus Hypersecretion in COPD and Death from Pulmonary Infection
Prescott, E., P. Lange, and J. Vestbo. 1995. “Chronic Mucus Hypersecretion in COPD and Death from Pulmonary Infection”. European Respiratory Journal. European Respiratory Society (ERS). doi:10.1183/09031936.95.08081333.
ChestJournal
Health Services Burden of Undiagnosed and Overdiagnosed COPD
Gershon, Andrea S., Deva Thiruchelvam, Kenneth R. Chapman, Shawn D. Aaron, Matthew B. Stanbrook, Jean Bourbeau, Wan Tan, and Teresa To. 2018. “Health Services Burden of Undiagnosed and Overdiagnosed COPD”. Chest. Elsevier BV. doi:10.1016/j.chest.2018.01.038.
Canadian Respiratory JournalJournal
Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2008 Update – Highlights for Primary Care
O’Donnell, Denis E, Paul Hernandez, Alan Kaplan, Shawn Aaron, Jean Bourbeau, Darcy Marciniuk, Meyer Balter, et al.. 2008. “Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2008 Update – Highlights for Primary Care”. Canadian Respiratory Journal. Hindawi Limited. doi:10.1155/2008/641965.
Respiratory MedicineJournal
The Clinical Utility of Long-term Humidification Therapy in Chronic Airway Disease
Rea, Harold, Sue McAuley, Lata Jayaram, Jeffrey Garrett, Hans Hockey, Louanne Storey, Glenis O'Donnell, Lynne Haru, Matthew Payton, and Kevin O'Donnell. 2010. “The Clinical Utility of Long-term Humidification Therapy in Chronic Airway Disease”. Respiratory Medicine. Elsevier BV. doi:10.1016/j.rmed.2009.12.016.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top